Signe Borgquist

7.8k total citations
167 papers, 3.6k citations indexed

About

Signe Borgquist is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Signe Borgquist has authored 167 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 84 papers in Cancer Research and 42 papers in Genetics. Recurrent topics in Signe Borgquist's work include Cancer Risks and Factors (65 papers), Cancer, Lipids, and Metabolism (43 papers) and Breast Cancer Treatment Studies (38 papers). Signe Borgquist is often cited by papers focused on Cancer Risks and Factors (65 papers), Cancer, Lipids, and Metabolism (43 papers) and Breast Cancer Treatment Studies (38 papers). Signe Borgquist collaborates with scholars based in Sweden, Denmark and United States. Signe Borgquist's co-authors include Jonas Manjer, Karin Jirström, Göran Landberg, Siker Kimbung, Pär‐Ola Bendahl, Ann H. Rosendahl, Salma Butt, Lola Anagnostaki, Karin Elebro and Lisa Rydén and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Signe Borgquist

154 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Signe Borgquist Sweden 34 1.9k 1.4k 1.1k 764 706 167 3.6k
Marc Debled France 30 1.5k 0.8× 1.9k 1.4× 716 0.7× 1.1k 1.4× 292 0.4× 121 3.8k
Iulia Cristina Tudor United States 19 750 0.4× 1.9k 1.3× 788 0.7× 1.1k 1.5× 552 0.8× 51 3.8k
Haojie Li China 27 675 0.4× 912 0.7× 1.0k 1.0× 1.1k 1.5× 684 1.0× 137 3.8k
Tom Meade United Kingdom 14 1.0k 0.5× 1.2k 0.9× 679 0.6× 622 0.8× 606 0.9× 23 3.9k
Ayca Gucalp United States 24 1.1k 0.6× 1.9k 1.4× 902 0.8× 782 1.0× 175 0.2× 82 3.4k
Bernardo Bonanni Italy 38 2.0k 1.1× 2.4k 1.7× 2.3k 2.1× 584 0.8× 620 0.9× 189 5.8k
Carl Yoshizawa United States 31 1.1k 0.6× 1.1k 0.8× 810 0.8× 370 0.5× 415 0.6× 62 3.4k
Bent Ejlertsen Denmark 44 2.8k 1.5× 3.9k 2.8× 1.3k 1.2× 1.2k 1.6× 550 0.8× 252 6.4k
Darcy Spicer United States 29 813 0.4× 2.0k 1.5× 880 0.8× 675 0.9× 163 0.2× 91 3.8k
J. Michael Dixon United Kingdom 33 3.2k 1.7× 2.4k 1.7× 914 0.9× 802 1.0× 1.2k 1.7× 82 5.0k

Countries citing papers authored by Signe Borgquist

Since Specialization
Citations

This map shows the geographic impact of Signe Borgquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Signe Borgquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Signe Borgquist more than expected).

Fields of papers citing papers by Signe Borgquist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Signe Borgquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Signe Borgquist. The network helps show where Signe Borgquist may publish in the future.

Co-authorship network of co-authors of Signe Borgquist

This figure shows the co-authorship network connecting the top 25 collaborators of Signe Borgquist. A scholar is included among the top collaborators of Signe Borgquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Signe Borgquist. Signe Borgquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cronin‐Fenton, Deirdre, Signe Borgquist, Sara Alkner, et al.. (2025). Statin use and risk of breast cancer among women with benign breast disease: a Danish nationwide cohort study. British Journal of Cancer. 132(9). 828–836. 1 indexed citations
2.
3.
Cronin‐Fenton, Deirdre, et al.. (2024). Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups. Scientific Reports. 14(1). 14486–14486. 4 indexed citations
4.
Thacher, Jesse D., Anna Oudin, Kristoffer Mattisson, et al.. (2024). Road traffic noise and breast cancer: DNA methylation in four core circadian genes. Clinical Epigenetics. 16(1). 168–168. 1 indexed citations
5.
6.
Dias, André H., Karin Hjorthaug, Lars Christian Gormsen, et al.. (2024). Increased lesion detectability in patients with locally advanced breast cancer—A pilot study using dynamic whole-body [18F]FDG PET/CT. EJNMMI Research. 14(1). 31–31. 1 indexed citations
7.
Förnvik, Daniel, et al.. (2024). Deep learning analysis of serial digital breast tomosynthesis images in a prospective cohort of breast cancer patients who received neoadjuvant chemotherapy. European Journal of Radiology. 178. 111624–111624. 5 indexed citations
8.
9.
Christiansen, Peer, et al.. (2024). Impact of type 2 diabetes on complications after primary breast cancer surgery: Danish population-based cohort study. British journal of surgery. 111(3). 4 indexed citations
10.
Olsen, Jens, et al.. (2023). Improvements in Survival and Early Retirement Rates – Real-World Evidence on Danish Breast Cancer Patients 2004–2018. Cancer Management and Research. Volume 15. 43–53. 2 indexed citations
11.
Gabrielson, Marike, Mattias Hammarström, L. Magnus Bäcklund, et al.. (2023). Effects of tamoxifen on normal breast tissue histological composition: Results from a randomised six‐arm placebo‐controlled trial in healthy women. International Journal of Cancer. 152(11). 2362–2372. 6 indexed citations
12.
Bo, Anne, Therese Koops Grønborg, Ivar Sønbø Kristiansen, et al.. (2023). Danish Women Want to Participate in a Hypothetical Breast Cancer Screening with Harms and No Reduction in Mortality: A Cross-Sectional Survey. Medical Decision Making. 43(4). 403–416. 4 indexed citations
13.
Sandén, Emma, Somayeh Khazaei, Dean P. Edwards, et al.. (2021). The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study. Frontiers in Oncology. 11. 642768–642768. 6 indexed citations
14.
Chandran, Vineesh Indira, Ann‐Sofie Månsson, Myriam Cerezo-Magaña, et al.. (2020). Hypoxia Attenuates Trastuzumab Uptake and Trastuzumab-Emtansine (T-DM1) Cytotoxicity through Redistribution of Phosphorylated Caveolin-1. Molecular Cancer Research. 18(4). 644–656. 25 indexed citations
15.
Bjarnadottir, Olöf, Siker Kimbung, Ida Johansson, et al.. (2015). Global Transcriptional Changes Following Statin Treatment in Breast Cancer. Clinical Cancer Research. 21(15). 3402–3411. 45 indexed citations
16.
Förnvik, Daniel, Kristina Lång, Ingvar Andersson, et al.. (2015). ESTIMATES OF BREAST CANCER GROWTH RATE FROM MAMMOGRAMS AND ITS RELATION TO TUMOUR CHARACTERISTICS. Radiation Protection Dosimetry. 169(1-4). 151–157. 32 indexed citations
17.
Wirfält, Elisabet, Cairu Li, Jonas Manjer, et al.. (2011). Food Sources of Fat and Sex Hormone Receptor Status of Invasive Breast Tumors in Women of the Malmö Diet and Cancer Cohort. Nutrition and Cancer. 63(5). 722–733. 14 indexed citations
18.
Ericson, Ulrika, Signe Borgquist, Emily Sonestedt, et al.. (2010). Plasma Folate Concentrations Are Positively Associated with Risk of Estrogen Receptor β Negative Breast Cancer in a Swedish Nested Case Control Study ,. Journal of Nutrition. 140(9). 1661–1668. 32 indexed citations
19.
Larsson, Anna-Maria, Linda Holmquist Mengelbier, Esther Bridges, et al.. (2008). Hypoxia-Inducible Factor-2α Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer. Cancer Research. 68(22). 9212–9220. 111 indexed citations
20.
Borgquist, Signe, Elisabet Wirfält, Karin Jirström, et al.. (2007). Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators. Breast Cancer Research. 9(1). R11–R11. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marc Debled Breakdown of academic impact, for papers by Iulia Cristina Tudor Breakdown of academic impact, for papers by Haojie Li Breakdown of academic impact, for papers by Tom Meade Breakdown of academic impact, for papers by Ayca Gucalp Breakdown of academic impact, for papers by Bernardo Bonanni Breakdown of academic impact, for papers by Carl Yoshizawa Breakdown of academic impact, for papers by Bent Ejlertsen Breakdown of academic impact, for papers by Darcy Spicer Breakdown of academic impact, for papers by J. Michael Dixon
Rankless by CCL
2026